Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Lantheus Medical Imaging announces the launch of ABLAVAR

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVAR™ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).

20 Jan 2010

Most Americans knowledgeable about heart health, but do not exercise or maintain a healthy diet

A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.

20 Jan 2010

Reliv International offers fundamental tips to prevent heart disease

This February, in honor of American Heart Month, Reliv International, a nutrition and direct selling company, is encouraging local residents to be proactive about their heart health. The proper approach, Reliv says, should include more than just avoiding certain activities and foods.

20 Jan 2010

Besides LDL, Lp(a) can also increase risk for heart disease

LDL isn't the only "bad boy" when it comes to cholesterol. According to a new study, a lipoprotein in the bloodstream called Lp(a) — pronounced "LP little A" — can be labeled "bad cholesterol."

20 Jan 2010

Statins may protect SCD children from pneumococcal infection

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

Erectile dysfunction can be strongly related to the development of CVD

In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).

20 Jan 2010

New issue from Annals of Internal Medicine

Prescriptions of some opioids, such as oxycodone, have increased significantly over the past decade. As long-term opioid therapy for chronic noncancer pain becomes more common, the deaths associated with opioids increase.

19 Jan 2010

HDL launches new preventative model to help physicians manage chronic diseases

Health Diagnostic Laboratory Inc. (HDL), www.hdlabinc.com, announced today the launch of its new preventative model to chronic disease management based off a monumental shift in the way physicians test for life threatening conditions.

19 Jan 2010

Scientists publish study on the effects of nutritional supplement ingredients on cholesterol levels

In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine.

19 Jan 2010

U-M's tailored treatment more effective against heart attacks

A new study by the University of Michigan Medical School and VA Ann Arbor Health System challenges the medical thinking that the lower the cholesterol, the better.

19 Jan 2010

Canadians consume more than double the recommended amount of sodium daily, study says

In advance of February's Heart Month, a new survey finds that 70 per cent of Canadians are concerned about the level of sodium in their diet. There is also vast confusion around sodium: over one-third of Canadians claim to know the upper sodium limit yet nearly nine out of 10 people get it wrong; and more than half of the population does not understand sodium information on nutrition labels. Canadians consume on average 3,092 milligrams of sodium daily, more than double the recommended amount of 1200 to 1500 milligrams.

18 Jan 2010

Scientists determine structure of enzyme essential to the survival of protozoan parasites

After many years of study, a team of researchers is releasing data today that it hopes will lead to new drug therapies that will kill the family of parasites that causes a deadly trio of insect-borne diseases and has afflicted inhabitants of underdeveloped and developing nations for centuries.

18 Jan 2010

Down syndrome and Alzheimer's disease are the same

Nearly 20 years ago Huntington Potter kicked up a storm of controversy with the idea that Down syndrome and Alzheimer's were the same disease. Now the evidence is in: He was right.

18 Jan 2010

Research suggests mail-order pharmacies are associated with better medication adherence

Buying medicine by mail may encourage patients to stick to their doctor-prescribed medication regimen, new research suggests.

18 Jan 2010

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the “RNA Silencing: Mechanism, Biology and Application” Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.

18 Jan 2010

Bariatric surgery offers a new hope for obese patients

Obesity is a condition that often follows family lines, but bariatric surgery offers hope for breaking this generational pattern.

18 Jan 2010

AACE sends petition to Congress opposing new Medicare policy

The American Association of Clinical Endocrinologists (AACE) sent a petition to Congress today signed by 1,325 AACE members, non-AACE member physicians, allied health professionals and patients opposing a new Medicare policy which would eliminate consultation codes for specialists.

13 Jan 2010

Majority of doctors appear to ignore FDA warning to screen high-risk medications

A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general.

13 Jan 2010

Research suggests variation of CETP gene is linked to lowered risk of dementia and AD

Preliminary research suggests that variation of a gene for a plasma protein is associated with slower age-related memory decline and a lower risk of dementia and Alzheimer disease (AD), according to a study in the January 13 issue of JAMA.

13 Jan 2010

Cholesterol News and Research

Further Reading

Lantheus Medical Imaging announces the launch of ABLAVAR

Most Americans knowledgeable about heart health, but do not exercise or maintain a healthy diet

Reliv International offers fundamental tips to prevent heart disease

Besides LDL, Lp(a) can also increase risk for heart disease

Statins may protect SCD children from pneumococcal infection

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Erectile dysfunction can be strongly related to the development of CVD

New issue from Annals of Internal Medicine

HDL launches new preventative model to help physicians manage chronic diseases

Scientists publish study on the effects of nutritional supplement ingredients on cholesterol levels

U-M's tailored treatment more effective against heart attacks

Canadians consume more than double the recommended amount of sodium daily, study says

Scientists determine structure of enzyme essential to the survival of protozoan parasites

Down syndrome and Alzheimer's disease are the same

Research suggests mail-order pharmacies are associated with better medication adherence

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Bariatric surgery offers a new hope for obese patients

AACE sends petition to Congress opposing new Medicare policy

Majority of doctors appear to ignore FDA warning to screen high-risk medications

Research suggests variation of CETP gene is linked to lowered risk of dementia and AD

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News